First in Human Study of AZD9592 in Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

403

Participants

Timeline

Start Date

December 22, 2022

Primary Completion Date

October 6, 2027

Study Completion Date

October 6, 2027

Conditions
Advanced Solid TumoursCarcinoma Non-small Cell LungHead and Neck NeoplasmsColorectal Neoplasms
Interventions
DRUG

AZD9592

Varying doses of AZD9592

DRUG

Osimertinib

tablets administered orally

DRUG

5-Fluorouracil (5-FU)

IV infusion

DRUG

Leucovorin

IV infusion

DRUG

Bevacizumab

IV infusion

Trial Locations (50)

333

RECRUITING

Research Site, Taoyuan District

2217

RECRUITING

Research Site, Kogarah

3000

RECRUITING

Research Site, Melbourne

8035

RECRUITING

Research Site, Barcelona

10002

RECRUITING

Research Site, Taipei

10016

RECRUITING

Research Site, New York

10021

RECRUITING

Research Site, New York

10029

RECRUITING

Research Site, New York

10043

RECRUITING

Research Site, Orbassano

11217

RECRUITING

Research Site, Taipei

11501

RECRUITING

Research Site, Mineola

13385

RECRUITING

Research Site, Marseille

19104

RECRUITING

Research Site, Philadelphia

20016

RECRUITING

Research Site, Washington D.C.

20089

RECRUITING

Research Site, Rozzano

20162

RECRUITING

Research Site, Milan

21224

RECRUITING

Research Site, Baltimore

21231

RECRUITING

Research Site, Baltimore

22031

RECRUITING

Research Site, Fairfax

28040

RECRUITING

Research Site, Madrid

35000

RECRUITING

Research Site, Rennes

37134

RECRUITING

Research Site, Verona

40705

RECRUITING

Research Site, Taichung

41013

RECRUITING

Research Site, Seville

59100

NOT_YET_RECRUITING

Research Site, Kuala Lumpur

60637

RECRUITING

Research Site, Chicago

77030

RECRUITING

Research Site, Houston

91010

RECRUITING

Research Site, Duarte

92618

WITHDRAWN

Research Site, Irvine

93586

RECRUITING

Research Site, Kuching

94805

RECRUITING

Research Site, Villejuif

100142

RECRUITING

Research Site, Beijing

NOT_YET_RECRUITING

Research Site, Beijing

150049

NOT_YET_RECRUITING

Research Site, Harbin

400030

RECRUITING

Research Site, Chongqing

430022

RECRUITING

Research Site, Wuhan

510100

RECRUITING

Research Site, Guangzhou

06473

RECRUITING

Research Site, North Haven

01757

RECRUITING

Research Site, Milford

02903

RECRUITING

Research Site, Providence

T6G 1Z2

RECRUITING

Research Site, Edmonton

M5G 1X6

RECRUITING

Research Site, Toronto

104-0045

RECRUITING

Research Site, Chūōku

277-8577

RECRUITING

Research Site, Kashiwa

135-8550

NOT_YET_RECRUITING

Research Site, Kōtoku

541-8567

NOT_YET_RECRUITING

Research Site, Osaka

03080

RECRUITING

Research Site, Seoul

03722

RECRUITING

Research Site, Seoul

05505

RECRUITING

Research Site, Seoul

06351

RECRUITING

Research Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY